I would love Chinese company own DCVax-L and all derivatives. The US FDA is too slow, shorts have no conscience, and traders care not for lives and survival of NWBO. Patients with glioblastoma deserve DCVax now and any effort to slow that down is an attack on those patients. The data more than supports that the biologic DCVax-L should be readily available to all in medical community and patients in need now.